3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
21
Carcinoma, Non-Small-Cell Lung
20
Melanoma
19
Neoplasms
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
6
Prostatic Neoplasms
6
Neoplasm Metastasis
6
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Stomach Neoplasms
5
Rectal Neoplasms
5
Hodgkin Disease
5
Adenocarcinoma Of Esophagus
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Multiple Myeloma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Brain Neoplasms
3
Anus Neoplasms
3
Anal Canal Carcinoma
3
Interventions
Cyclophosphamide
7
Mycophenolic Acid
5
Whole-Body Irradiation
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Tacrolimus
3
Rituximab
3
Prednisone
3
Methotrexate
3
Inotuzumab Ozogamicin
3
Etoposide
3
Cytarabine
3
Cyclosporine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
asciminib
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mercaptopurine
2
Filgrastim
2
Dexamethasone
2
Calcium Dobesilate
2
tocilizumab
1
ricolinostat
1
rasburicase
1
ponatinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Nivolumab
×
30 days
×
Clear all
No trials found.